Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes

Obesity Research

Volumn 8, Issue 7, 2000, Pages 530-539

  Mueller, Wendy M ^a   Stanhope, Kimber L ^a   Gregoire, Francine ^a   Evans, Joseph L ^b   Havel, Peter J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Medical Research Institute Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anaerobic metabolism; Glucose uptake; Lactate production

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN; LACTIC ACID; LEPTIN; METFORMIN; VANADIUM;

ADIPOCYTE; ANIMAL; ARTICLE; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; MALE; METABOLISM; RAT; REGRESSION ANALYSIS; SECRETION; SPRAGUE DAWLEY RAT; TIME;

ADIPOCYTES; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HYPOGLYCEMIC AGENTS; INSULIN; LACTIC ACID; LEPTIN; MALE; METFORMIN; RATS; RATS, SPRAGUE-DAWLEY; REGRESSION ANALYSIS; TIME FACTORS; VANADIUM;

EID: 0034302911     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2000.66     Document Type: Article

References (56)

1. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763-770.
2. Havel PJ. Mechanisms regulating leptin production: implications for control of to energy balance. Am J Clin Nutr. 1999; 70:305-306.
3. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-295.
4. Havel PJ, Kasim-Karakas S, Mueller WM, Johnson PR, Gingerich RL, Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab. 1996;8:4406-13.
5. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodents measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1: 1155-61.
6. Ahren B, Mansson S, Gingerich RL, Havel PJ. Regulation of plasma leptin in mice: influence of age, high-fat diet and fasting. Am J Physiol. 1997;273:R113-R20.
7. Havel PJ. Glucose infusion increases circulating leptin in proportion to adipose stores in rhesus monkeys. J Exp Endocrinol Diabetes. 1997;105(Suppl 3):37-8.
8. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab. 1996;81:3419-23.
9. Kolaczynski JW, Considine RV, Ohannesian J, et al. Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes. 1996;45:1511-15.
10. Weigle DS, Duell PB, Conner WE, et al. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab. 1997;82:561-5.
11. Dubuc GR, Phinney SD, Stern JS, Havel PJ. Changes of serum leptin and endocrine and metabolic parameters after 7 days energy restriction in men and women. Metab Clin Exp. 1998;47:429-34.
12. Keim NL, Stern JS, Havel PJ. Relationship between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women. Am J Clin Nutr. 1998;68: 794-801.
13. Kolaczynski JW, Ohannesian JP, Considine RV, Marco CC, Caro JF. Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab. 1996;81: 4162-5.
14. Dagogo-Jack SC, Fanelli D, Paramore J, Brothers, Landt M. Plasma leptin and insulin relationships in obese and nonobese human. Diabetes. 1996;45:695-8.
15. Kolaczynski JW, Nyce MR, Considine RV, et al. Acute and chronic effect of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes. 1996;45:699-701.
16. Havel PJ, Aoki TT, Grecu EO, Stern JS, Kasim-Karakas S. Leptin/adiposity relationships in intensively treated IDDM and NIDDM and increased plasma leptin after 6 hours of high dose insulin infusion. Obes Res. 1996;4:15S.
17. Utriainen R, Malmstrom R, Makimattila S, Yki-Jarvinen H. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects. Diabetes. 1996;45:1364-6.
18. Saad MF, Khan A, Sharma A, et al. Physiological insulinemia acutely modulates plasma leptin. Diabetes. 1998;47: 544-9.
19. Grinspoon SK, Askari H, Landt ML, et al. Effects of fasting and glucose infusion on basal and overnight leptin concentrations in normal-weight women. Am J Clin Nutr. 1997;66: 1352-6.
20. Havel PJ, Townsend R, Chaump L, Teff K. High fat meals reduce 24 hour circulating leptin concentrations in women. Diabetes. 1999;48:334-41.
21. Gettys TW, Harkness PJ, Watson PM. The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rats adipocytes. Endocrinology. 1996;137:4054-7.
22. Leroy P, Dessolin S, Villageois P, et al. Expression of ob gene in adipose cells: regulation by insulin. J Biol Chem. 1996;271:2365-8.
23. Yoshida T, Hayashi M, Monkawa T, Saruta T. Regulation of obese mRNA expression by hormonal factors in primary cultures of rat adipocytes. Eur J Endocrinol. 1996;135: 619-25.
24. Wabitsch M, Jensen PB, Blum WF, et al. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes. 1996;45:1435-8.
25. Mizuno T, Bergen H, Kleopoulos S, Bauman WA, Mobbs CV. Effects of nutritional status and aging on leptin gene expression in mice: importance of glucose. Horm Metab Res. 1996;28:679-84.
26. Mizuno TM, Bergen H, Funabashi T, et al. Obese gene expression: reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity. Proc Natl Acad Sci USA. 1996;93:3434-8.
27. Havel PJ, Uriu-Hare JY, Stanhope KL, Stern JS, Keen CL, Ahren B. Marked and rapid decrease of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol. 1998;274:R1482-R91.
28. Mueller WM, Gregoire FM, Stanhope KL, et al. Evidence that glucose metabolism regulates leptin secretion from isolated adipocytes. Endocrinology. 1998;139:551-8.
29. Cusi K, DeFronzo RA. Metformin: a review of its metabolic effects. Diabetes Rev. 1998;6:89-131.
30. Sekar N, Li J, Shechter Y. Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research. Crit Rev Biochem Mol Biol. 1996;31:339-59.
31. McNeill JH, Yuen VG, Dai S, Orvig C. Increased potency of vanadium using organic ligands. Mol Cell Biochem. 1995;153: 175-80.
32. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem. 1964;239:375-80.
33. Fantus IG, Brosseau R. Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo. J Clin Endocrinol Metab. 1986;63:898-905.
34. Klip A, Leiter LA. Cellular mechanism of action of metformin. Diabetes Care. 1990;13:696-704.
35. Molero JC, Martinez C, Andres A, Satrustegui J, Carrascosa JM. Vanadate fully stimulates insulin receptor substrate-1 associated phosphatidyl inositol 3-kinase activity in adipocytes from young and old rats. FEBS Lett. 1998;425: 298-304.
36. Nakai M, Watanabe H, Fujiwara C, et al. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds. Biol Pharm Bull. 1995;18:719-25.
37. Landt M, Gingerich RL, Havel PJ, et al. Radioimmunoassay of rat leptin: sexual dimorphism reversed from humans. Clin Chem. 1998;44:565-70.
38. Kallen CB, Lazar M. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA. 1996;93:5793-6.
39. Nolan JJ, Olefsky JM, Nyce MR, Considine RV, Caro JF. Effect of troglitazone on leptin production in vitro and in human subjects. Diabetes. 1996;45:1276-8.
40. Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 1996;30:359-71.
41. Shulman G. Cellular mechanisms of insulin resistance in humans. Am J Cardiol. 1999;84:3J-10J.
42. Inzucchi SE, Maggs DG, Spollett GR, et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med. 1998;338:867-72.
43. Jackson RA, Hawa MI, Jaspan JB, et al. Mechanism of metformin action in non-insulin-dependent diabetes. Diabetes. 1987;36:632-40.
44. Pedersen O, Nielson OH, Bak J, et al. The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes. Diabetic Med. 1989;6: 249-56.
45. Fischer Y, Thomas J, Rosen P, Kammermeier H. Action of metformin on glucose transport and glucose transporter GLUT1 and GLUT4 in heart muscle cells from healthy and diabetic rats. Endocrinology. 1995;136:412-20.
46. Jacobs DB, Hayes GR, Truglia JA, Lockwood DH. Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes. Diabetologia. 1986;29:798-801.
47. Di Paolo S. Metformin ameliorates extreme insulin resistance in a patient with anti-insulin receptor antibodies: description of insulin receptor and postreceptor effects in vivo and in vitro. Acta Endocrinol. 1992;126:117-23.
48. Kozka IJ, Holman GD. Metformin blocks downregulation of cell surface GLUT4 caused by chronic insulin treatment of rat adipocytes. Diabetes. 1993;42:1159-65.
49. Dunn CJ, Peters DH. Metformin: a review of its pharmacological properties and therapeutic use in non-insulin dependent diabetes mellitus. Drugs. 1995;49:721-49.
50. DiGirolamo M, Newby FD, Lovejoy J. Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J. 1992;6:2405-12.
51. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature. 1998;393:684-8.
52. Yuen VG, Orvig C, McNeill JH. Effects of bis(maltolato-)oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats. Am J Physiol. 1997;272:E30-E5.
53. Yuen VG, Orvig C, McNeill JH. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. Can J Physiol Pharmacol. 1995;73:55-64.
54. Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rossetti L. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1995;95: 2501-9.
55. Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CR. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab. 1995; 80:3311-20.
56. Tsiani E, Fantus IG. Vanadium compounds: biological actions and potential as pharmacological agents. Trends Endocrinol Metab. 1997;8:51-8.